Recent research unveiled that TRIM24 upregulated in glioblastoma, and it accelerated tumor growth and induced chemotherapy resistance via the phosphatidylinositide 3-kinase (PI3K)/Akt pathway [15]. This evidence concerns the gene AKT1 and neoplasm.